A Short, Efficient Copper-Mediated Synthesis of 1α,25-Dihydroxyvitamin D2 (1α,25-Dihydroxyergocalciferol) and C-24 Analogs

Journal of Organic Chemistry

Volumn 62, Issue 18, 1997, Pages 6344-6352

  Torneiro, Mercedes ^a   Fall, Yagamare ^a   Castedo, Luis ^a   Mouriño, Antonio ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000631889     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo970604u     Document Type: Article

References (95)

1. This paper is dedicated to Professor Dieter Seebach in honor of his 60th birthday.
2. This work was taken in part from the doctoral thesis of Mercedes Torneiro (University of Santiago de Compostela, January 1994).
3. Norman, A. W. Vitamin D, The Calcium Homeostatic Steroid Hormone; Academic Press: New York, 1979.
4. (a) Honma, Y.; Hozumi, M.; Abe, E.; Konno, K.; Fukushima, M.; Hata, S.; Nishii, Y.; DeLuca, H. F.; Suda, T. Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 201.
5. (b) Sato, T.; Takuagawa, K.; Asoo, N.; Konno, K. Br. J. Cancer 1984, 50, 123.
6. (c) Eisman, J. A.; Barkla, D. H.; Tutton, J. M. Cancer Res. 1987, 47, 21.
7. (d) Uskokovic, M. R. Recent Advances in Vitamin D Chemistry and Pharmacological Activity. Bioorg. Med. Chem. Lett. 1993, 3, 1783.
8. (e) Vitamin D, A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications] Norman, A. W., Bouillon, R., Thomasset, M., Eds.; Walter de Gruyter: Berlin, 1994.
9. (a) Leukemia: Inaba, M.; Koyama, H.; Hino, M.; Okuno, S.; Terada, M.; Nishizawa, Y.; Nishino, T.; Morii, H. Blood 1993, 82, 53.
10. (b) Breast: Wijngaarden, T. V.; Pols, H. A. P.; Buurman, C. J.; Birkenhäger, J. C.; van Leeuwen, J. P. T. M. Breast Cancer Res. Treat. 1994, 29, 161 and refs therein.
11. (c) Prostate: Skowronski, R. J.; Peehl, D. M.; Feldman, D. Endocrinology 1995, 136, 20.
12. (a) DeLuca, H. F. FASEB 1987, 224.
13. (b) Nodin, B. E. C.; Morris, H. A. J. Cell. Biochem. 1992, 49, 19.
14. (a) Kragballe, K. J. Cell. Biochem. 1992, 49, 46.
15. (b) van de Kerkhof, P. C. M. Br. J. Dermatol. 1995, 232, 675 and references therein.
16. Connor, R. I.; Rigby, W. F. C. Biochem. Biophys. Res. Commun. 1991, 176, 852.
17. DeLuca, H. F. Handb, Physiol. 1978, 7, 265.
18. Jones, G.; Schnoes, H. K.; DeLuca, H. F. Biochemistry 1975, 14, 1250.
19. (a) Norman, A. W.; Roth, J.; Orci, L. Endocr. Rev. 1982, 3, 331.
20. (b) Reddy, G. S.; Tserng, K. Biochemistry 1986, 25, 5328 and references therein,
21. (c) Koszewski, N. J.; Reinhardt, T. A.; Napoli, J. L.; Beitz, D. C.; Horst, R. L. Biochemistry 1988, 27, 5785.
22. 3 series: (a) Tjellesen, L.; Gotfredsen, A.; Christiansen, C. Calcif. Tissue Int. 1985, 37, 218. (b) Sjoden, G.; Smith, C.; Lindgren, U.; DeLuca, H. F. Proc. Soc. Exp. Biol. Med. 1985, 178, 432.
23. 3 series: (a) Tjellesen, L.; Gotfredsen, A.; Christiansen, C. Calcif. Tissue Int. 1985, 37, 218. (b) Sjoden, G.; Smith, C.; Lindgren, U.; DeLuca, H. F. Proc. Soc. Exp. Biol. Med. 1985, 178, 432.
24. 2: Drescher, D.; DeLuca, H. F.; Imrie, H. H. Arch. Biochem. Biophys. 1969, 130, 657.
25. (a) Reddy, G. S.; Tseng, K.-Y. Biochem. 1986, 25, 5328.
26. (b) Clark, J. W.; Reddy, G. S.; Santos-Moore, A.; Wankadiya, K. F.; Reddy, G. P.; Eil, C.; Lasky, S.; Tserng, K.-Y., Horst, R. L.; Uskokovic', M. R. Bioorg. Med. Chem. Lett. 1993, 3, 1873.
27. (a) Reinhardt, T. A.; Ramberg, C. F.; Horst, R. L. Arch. Biochem. Biophys. 1989, 273, 64.
28. (b) Norman, A. W.; Koeffler, H. P.; Bishop, J. E.; Collins, E. D.; Sergeev, I.; Zhou, L. X.; Nemer, I.; Zhou, J.; Henry, H. L.; Okamura, W. H. In Vitamin D: Gene Regulation, Structure- function Analysis and Clinical Application; Norman, A. W., Bouillon, R., Thomasset, M., Eds; Walter de Gruyter: Berlin, 1991; p 146.
29. Bouillon, R.; Okamura, W. H.; Norman, A. W. Endocr. Rev. 1995, 16, 200.
30. 3, which has been identified as a potential antiosteoporotic agent; see Drezner, M. K.; Nesbitt, T. In Vitamin D: Gene Regulation, Structure-function Analysis and Clinical Application; Norman, A. W., Bouillon, R., Thomasset, M., Eds.; Walter de Gruyter: Berlin, 1991; p 816. EB-1089, which inhibits the growth of breast cancer cells in vitro and in vivo; see Binderup, L. Bioorg. Med. Chem. Lett. 1993, 3, 1891.
31. 3, which has been identified as a potential antiosteoporotic agent; see Drezner, M. K.; Nesbitt, T. In Vitamin D: Gene Regulation, Structure-function Analysis and Clinical Application; Norman, A. W., Bouillon, R., Thomasset, M., Eds.; Walter de Gruyter: Berlin, 1991; p 816. EB-1089, which inhibits the growth of breast cancer cells in vitro and in vivo; see Binderup, L. Bioorg. Med. Chem. Lett. 1993, 3, 1891.
32. 3, which has been identified as a potential antiosteoporotic agent; see Drezner, M. K.; Nesbitt, T. In Vitamin D: Gene Regulation, Structure-function Analysis and Clinical Application; Norman, A. W., Bouillon, R., Thomasset, M., Eds.; Walter de Gruyter: Berlin, 1991; p 816. EB-1089, which inhibits the growth of breast cancer cells in vitro and in vivo; see Binderup, L. Bioorg. Med. Chem. Lett. 1993, 3, 1891.
33. 2, but its therapeutical utility has not yet been studied: Maestro, M. A.; Castedo, L.; Mouriño, A. J. Org. Chem. 1992, 57, 5208.
34. 2, but its therapeutical utility has not yet been studied: Maestro, M. A.; Castedo, L.; Mouriño, A. J. Org. Chem. 1992, 57, 5208.
35. 2, but its therapeutical utility has not yet been studied: Maestro, M. A.; Castedo, L.; Mouriño, A. J. Org. Chem. 1992, 57, 5208.
36. 2, but its therapeutical utility has not yet been studied: Maestro, M. A.; Castedo, L.; Mouriño, A. J. Org. Chem. 1992, 57, 5208.
37. 2, but its therapeutical utility has not yet been studied: Maestro, M. A.; Castedo, L.; Mouriño, A. J. Org. Chem. 1992, 57, 5208.
38. 2 inhibits the proliferation of keratinocytes and sebocytes with low calcium liability, and stimulates renal vitamin D receptor without causing hypercalcemia: (a) Choudhry, S. C.; Belica, P. S.; Coffen, D. L.; Foella, A.; Maehr, H.; Manchand, P. S.; Serico, L.; Yang, R. T. J. Org. Chem. 1993, 8, 1496. (b) Goff, J. P.; Horst, R. L.; Uskokovic', M. R. Bioorg. Med. Chem. Lett. 1993, 3, 1825.
39. 2 inhibits the proliferation of keratinocytes and sebocytes with low calcium liability, and stimulates renal vitamin D receptor without causing hypercalcemia: (a) Choudhry, S. C.; Belica, P. S.; Coffen, D. L.; Foella, A.; Maehr, H.; Manchand, P. S.; Serico, L.; Yang, R. T. J. Org. Chem. 1993, 8, 1496. (b) Goff, J. P.; Horst, R. L.; Uskokovic', M. R. Bioorg. Med. Chem. Lett. 1993, 3, 1825.
40. (a) Piatak, D. M.; Wicha, J. Chem. Rev. 1978, 78, 199.
41. (b) Lythgoe, B. Chem. Soc. Rev. 1980, 9, 449.
42. (c) Redpath, J.; Zeele, E. J. J. Chem. Soc. Rev. 1983, 12, 75-98.
43. (d) Pardo, R.; Santelli, M. Bull. Soc. Chim. Fr. 1985, 98.
44. (e) Quinkert, G. Vitamin D Active Compounds. Part I. Synform 1985, 3, 41.
45. (f) Part II. Ibid. 1986, 4, 131.
46. (g) Part III. Ibid. 1987, 5, 1.
47. (h) Wilson, S. R.; Yasmin, A. Stereoselective Synthesis of Vitamin D. In Studies in Natural Products Chemistry; Atta-ur-Rahman., Ed.; Elsevier: Amsterdam, 1992, Vol. 10, p 43.
48. (i) Dai, H.; Pösner, G. H. Synthesis 1994, 1383.
49. (j) Schmalz, H.-G. Nachr. Chem. Tech. Lab. 1994, 42, 397.
50. (k) Zhu, G.-D.; Okamura, W. H. Chem. Rev. 1995, 1877.
51. Hanekamp, J. C.; Rookhuizen, R. B.; v. d. Heuvel, H. L. A.; Bos, H. J. T.; Brandsrna, L. Tetrahedron Lett. 1991, 32, 5397.
52. Although the overall yield of the Julia olefination method is genearally lower than that of the Wittig approach, high yields have been obtained in some cases. For examples of the Julia olefination, see; (a) Yamada, S.; Shiraishi, M.; Ohmori, M.; Takayama, H. Tetrahedron Lett. 1984, 25, 3347. (b) Wicha, J.; Bal, K.; Piekut, S. Synth. Commun. 1977, 7, 215. (c) Perlman, K. L.; Sicinski, R. R.; Phelps, M. E.; Schnoes, H. K.; DeLuca, H. F. Tetrahedron Lett. 1987, 28, 6129. (d) Sicinski, R. R.; DeLuca, H. F.; Schnoes, H. K.; Tanaka, Y.; Smith, C. M. Bioorg. Chem. 1987, 15, 15. (e) Perlman, K. L.; DeLuca, H. F. Tetrahedron Lett. 1992, 33, 2937. (f) Kutner, A.; Chodynski, M.; Halkes, S. J.; Brugman. J. Bioorg. Chem. 1993, 21, 13.
53. Although the overall yield of the Julia olefination method is genearally lower than that of the Wittig approach, high yields have been obtained in some cases. For examples of the Julia olefination, see; (a) Yamada, S.; Shiraishi, M.; Ohmori, M.; Takayama, H. Tetrahedron Lett. 1984, 25, 3347. (b) Wicha, J.; Bal, K.; Piekut, S. Synth. Commun. 1977, 7, 215. (c) Perlman, K. L.; Sicinski, R. R.; Phelps, M. E.; Schnoes, H. K.; DeLuca, H. F. Tetrahedron Lett. 1987, 28, 6129. (d) Sicinski, R. R.; DeLuca, H. F.; Schnoes, H. K.; Tanaka, Y.; Smith, C. M. Bioorg. Chem. 1987, 15, 15. (e) Perlman, K. L.; DeLuca, H. F. Tetrahedron Lett. 1992, 33, 2937. (f) Kutner, A.; Chodynski, M.; Halkes, S. J.; Brugman. J. Bioorg. Chem. 1993, 21, 13.
54. Although the overall yield of the Julia olefination method is genearally lower than that of the Wittig approach, high yields have been obtained in some cases. For examples of the Julia olefination, see; (a) Yamada, S.; Shiraishi, M.; Ohmori, M.; Takayama, H. Tetrahedron Lett. 1984, 25, 3347. (b) Wicha, J.; Bal, K.; Piekut, S. Synth. Commun. 1977, 7, 215. (c) Perlman, K. L.; Sicinski, R. R.; Phelps, M. E.; Schnoes, H. K.; DeLuca, H. F. Tetrahedron Lett. 1987, 28, 6129. (d) Sicinski, R. R.; DeLuca, H. F.; Schnoes, H. K.; Tanaka, Y.; Smith, C. M. Bioorg. Chem. 1987, 15, 15. (e) Perlman, K. L.; DeLuca, H. F. Tetrahedron Lett. 1992, 33, 2937. (f) Kutner, A.; Chodynski, M.; Halkes, S. J.; Brugman. J. Bioorg. Chem. 1993, 21, 13.
55. Although the overall yield of the Julia olefination method is genearally lower than that of the Wittig approach, high yields have been obtained in some cases. For examples of the Julia olefination, see; (a) Yamada, S.; Shiraishi, M.; Ohmori, M.; Takayama, H. Tetrahedron Lett. 1984, 25, 3347. (b) Wicha, J.; Bal, K.; Piekut, S. Synth. Commun. 1977, 7, 215. (c) Perlman, K. L.; Sicinski, R. R.; Phelps, M. E.; Schnoes, H. K.; DeLuca, H. F. Tetrahedron Lett. 1987, 28, 6129. (d) Sicinski, R. R.; DeLuca, H. F.; Schnoes, H. K.; Tanaka, Y.; Smith, C. M. Bioorg. Chem. 1987, 15, 15. (e) Perlman, K. L.; DeLuca, H. F. Tetrahedron Lett. 1992, 33, 2937. (f) Kutner, A.; Chodynski, M.; Halkes, S. J.; Brugman. J. Bioorg. Chem. 1993, 21, 13.
56. Although the overall yield of the Julia olefination method is genearally lower than that of the Wittig approach, high yields have been obtained in some cases. For examples of the Julia olefination, see; (a) Yamada, S.; Shiraishi, M.; Ohmori, M.; Takayama, H. Tetrahedron Lett. 1984, 25, 3347. (b) Wicha, J.; Bal, K.; Piekut, S. Synth. Commun. 1977, 7, 215. (c) Perlman, K. L.; Sicinski, R. R.; Phelps, M. E.; Schnoes, H. K.; DeLuca, H. F. Tetrahedron Lett. 1987, 28, 6129. (d) Sicinski, R. R.; DeLuca, H. F.; Schnoes, H. K.; Tanaka, Y.; Smith, C. M. Bioorg. Chem. 1987, 15, 15. (e) Perlman, K. L.; DeLuca, H. F. Tetrahedron Lett. 1992, 33, 2937. (f) Kutner, A.; Chodynski, M.; Halkes, S. J.; Brugman. J. Bioorg. Chem. 1993, 21, 13.
57. Although the overall yield of the Julia olefination method is genearally lower than that of the Wittig approach, high yields have been obtained in some cases. For examples of the Julia olefination, see; (a) Yamada, S.; Shiraishi, M.; Ohmori, M.; Takayama, H. Tetrahedron Lett. 1984, 25, 3347. (b) Wicha, J.; Bal, K.; Piekut, S. Synth. Commun. 1977, 7, 215. (c) Perlman, K. L.; Sicinski, R. R.; Phelps, M. E.; Schnoes, H. K.; DeLuca, H. F. Tetrahedron Lett. 1987, 28, 6129. (d) Sicinski, R. R.; DeLuca, H. F.; Schnoes, H. K.; Tanaka, Y.; Smith, C. M. Bioorg. Chem. 1987, 15, 15. (e) Perlman, K. L.; DeLuca, H. F. Tetrahedron Lett. 1992, 33, 2937. (f) Kutner, A.; Chodynski, M.; Halkes, S. J.; Brugman. J. Bioorg. Chem. 1993, 21, 13.
58. Wilson, S. R.; Davey, A. E.; Guazzaroni, M. E. J. Org. Chem. 1992, 57, 2007.
59. Harada, S.; Kiyono, H.; Taguchi, T.; Hanzawa, Y.; Shiro, M. Tetrahedron Lett. 1955, 36, 9489.
60. (a) Baggiolini, F. G.; Iacobelli, J. A. ; Hennessy, B. M.; Batcho, A. D.; Sereno, J. F.; Uskokovic', M. R. J. Org. Chem. 1986, 51, 3098.
61. (b) Batcho, A. D.; Sereno, J. F.; Hennessy, B. M.; Baggioloni, E. G.; Uskokovic', M. R.; Horst, R. L. Bioorg. Med. Chem. Lett. 1993, 3, 1821.
62. Schmittberger, T.; Uguen, D. Tetrahedron Lett. 1996, 37, 29.
63. Lythgoe, B.; Roberts, D. A.; Waterhouse, I. J. Chem. Soc., Perkin Trans. 1 1977, 2608.
64. (a) Sardina, F. J.; Mouriño, A.; Castedo, L. Tetrahedron Lett. 1983, 24, 4477.
65. (b) Sardina, F. J.; Mouriño, A.; Castedo, L. J. Org. Chem. 1986, 51, 1264.
66. (c) Granja, J. R.; Castedo, L.; Mouriño, A. J. Org. Chem. 1993, 58, 124.
67. Maestro, M. A. Doctoral Thesis, Santiago de Compostela, 1989.
68. For examples of subsitution reactions at an allylic carbon, see: (a) Yanagisawa, A.; Noritake, Y.; Nomura, N.; Yamamoto, H. Synlett 1991, 251 and references therein, (b) Yanagisawa, A.; Nomura, N.; Yamamoto, H. Synlett 1993, 689. (c) Flemming, S.; Kabbara, J.; Nickisch, K.; Westermann, J.; Mohr, J. Synlett 1995, 183. (d) Persson, S. M., Klaveen, M. v.; Grove, D. M.; Bäckvall, J. E.; Koten, G. v. Chem. Eur. J. 1995 J. 351 and references therein.
69. For examples of subsitution reactions at an allylic carbon, see: (a) Yanagisawa, A.; Noritake, Y.; Nomura, N.; Yamamoto, H. Synlett 1991, 251 and references therein, (b) Yanagisawa, A.; Nomura, N.; Yamamoto, H. Synlett 1993, 689. (c) Flemming, S.; Kabbara, J.; Nickisch, K.; Westermann, J.; Mohr, J. Synlett 1995, 183. (d) Persson, S. M., Klaveen, M. v.; Grove, D. M.; Bäckvall, J. E.; Koten, G. v. Chem. Eur. J. 1995 J. 351 and references therein.
70. For examples of subsitution reactions at an allylic carbon, see: (a) Yanagisawa, A.; Noritake, Y.; Nomura, N.; Yamamoto, H. Synlett 1991, 251 and references therein, (b) Yanagisawa, A.; Nomura, N.; Yamamoto, H. Synlett 1993, 689. (c) Flemming, S.; Kabbara, J.; Nickisch, K.; Westermann, J.; Mohr, J. Synlett 1995, 183. (d) Persson, S. M., Klaveen, M. v.; Grove, D. M.; Bäckvall, J. E.; Koten, G. v. Chem. Eur. J. 1995 J. 351 and references therein.
71. For examples of subsitution reactions at an allylic carbon, see: (a) Yanagisawa, A.; Noritake, Y.; Nomura, N.; Yamamoto, H. Synlett 1991, 251 and references therein, (b) Yanagisawa, A.; Nomura, N.; Yamamoto, H. Synlett 1993, 689. (c) Flemming, S.; Kabbara, J.; Nickisch, K.; Westermann, J.; Mohr, J. Synlett 1995, 183. (d) Persson, S. M., Klaveen, M. v.; Grove, D. M.; Bäckvall, J. E.; Koten, G. v. Chem. Eur. J. 1995, 1. 351 and references therein.
72. It is known that simple vinyl carbanions react with steroidal 22-aldehydes with poor stereoselectivity to give the Cram (R)-allylic alcohol as the major product. For a few examples, see: ref 20, and (a) Khripach, V. A.; Zhabinskiy, V. N.; Olkhovick, V. K. Tetrahedron Lett. 1990, 31, 4937. (b) Back, T. G.; Blazecka, P. G.; Krishna, M. V. Tetrahedron Lett. 1991, 32, 4817.
73. It is known that simple vinyl carbanions react with steroidal 22-aldehydes with poor stereoselectivity to give the Cram (R)-allylic alcohol as the major product. For a few examples, see: ref 20, and (a) Khripach, V. A.; Zhabinskiy, V. N.; Olkhovick, V. K. Tetrahedron Lett. 1990, 31, 4937. (b) Back, T. G.; Blazecka, P. G.; Krishna, M. V. Tetrahedron Lett. 1991, 32, 4817.
74. (a) Tseng, C. C.; Paisley, S. D.; Goering, H. L. J. Org. Chem. 1986, 51, 2884.
75. (b) Tseng, C. C.; Yen, S.-J., Goering H. L. ibid. 1986, 51, 2892 and references therein.
76. Torneiro, M. Doctoral Thesis, Santiago de Compostela, 1994.
77. Salomon, R. G.; Basu, B.; Roy, S.; Sachinvala, N. D. J. Am. Chem. Soc. 1991, 113, 3096.
78. (a) Wovkulich, P. M.; Barcelos, F.; Batcho, A. D.; Sereno, J. F.; Baggiolini, E. G.; Hennessy, B. B.; Uskokovic', M. R. Tetrahedron 1984, 40, 2283.
79. (b) Dauben, W. G.; Oilman, R. R.; Funhoff, A. S.; Neidlein, R. Tetrahedron Lett. 1989, 30, 677.
80. (c) Fernández, B.; Martínez-Pérez, J. A.; Granja, J. R.; Castedo, L.; Mouriño, A. J. Org. Chem. 1992, 57, 3173.
81. Murahashi, S.-I.; Taniguchi, Y.; Imada, Y.; Tanigawa, Y. J. Org. Chem. 1989, 54, 3292.
82. While this work was in progress, a catalytic version of the Yamamoto reaction appeared. See ref 30b.
83. 2 regioisomers and other stereoisomers with Z configuration at the double bond were chromatographically removed after desilylation.
84. 3 hormone receptor.
85. Marino, J. P.; Fernández de la Pradilla, R.; Laborde, E. J. Org. Chem. 1987, 52, 4898.
86. (a) Underiner, T. L.; Paisley, S. D.; Schmitter, J.; Lesheski, L.; Goering, H. L. J. Org. Chem. 1989, 54, 2369.
87. (b) Underiner, T. L.; Goering, H. L. Ibid. 1991, 56, 2563.
88. 3 and Analogues. Application to the Synthesis of Lythgoe-Roche Phosphine Oxide. Tetrahedron Lett. 1997, 38, 4713.
89. Poaner, G. H.; Johnson, N. J. Org. Chem. 1994, 59, 7855.
90. 2O have not been carried out.
91. Previous experiments carried out in our laboratory indicate that the Wittig-Horner type coupling gives the vitamin D triene unit in low yield when the amount of CD-side chain fragment used is lower than 50 mg.
92. Attempts to carry out this type of transformation using other cuprates have not been pursued although similar results are expected.
93. Kofron, W. G.; Badawski, L. M. J. Org. Chem. 1976, 41, 1879.
94. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923.
95. Corey, E. J.; Schmidt, G. Tetrahedron Lett. 1979, 399.